{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:43:59Z","timestamp":1792604639850,"version":"4.5.0"},"reference-count":85,"publisher":"BMJ","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1992,1]]},"abstract":"<jats:p>Gastro-oesophageal reflux disease is a common condition with a complex pathophysiology. Despite the spectrum of abnormalities, gastric acid has a central role in mucosal damage, and the mainstay of medical treatment is suppression of gastric acid secretion. The results of antisecretory treatment as assessed by endoscopic healing are reviewed. H2 receptor antagonists give more rapid symptom relief than placebo and can produce endoscopic improvement in 31-88% of cases depending on the severity of oesophagitis. Complete healing, however, is seen only in 27-45% of patients and these have mainly grades I-II disease. Improved healing rates can be obtained by increasing the degree of acid suppression or the length of treatment. The addition of a prokinetic agent may be beneficial. Omeprazole heals 67-92% of patients overall and although most successful in the lower grades of oesophagitis, can also heal 48-62% of patients with grade IV disease. The degree and rate of healing seem to be related to the reduction in oesophageal acid exposure and thus may correlate with the degree and duration of acid suppression over 24 hours obtained by the various treatments. The underlying pathophysiology is unchanged, however, and long term treatment may be needed to maintain remission.<\/jats:p>","DOI":"10.1136\/gut.33.1.118","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"118-124","source":"Crossref","is-referenced-by-count":138,"title":["Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease."],"prefix":"10.1136","volume":"33","author":[{"given":"N J","family":"Bell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R H","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1992,1,1]]},"reference":[{"key":"ref_1","first-page":"953","article-title":"Symptomatic gastroesophageal reflux: Incidence and precipitating factors","volume":"21","author":"Nebel, O.T.; Forbes, M.F.; Castell, D.O.","year":"1976","unstructured":"Nebel OT, Forbes MF, Castell DO. Symptomatic gastroesophageal reflux: Incidence and precipitating factors. AmJ7 DigDis 1976; 21: 953-6."},{"key":"ref_2","first-page":"257","article-title":"Why do apparently healthy people use antacid tablets?","volume":"78","author":"Graham, D.Y.; Smith, J.L.; Patterson, D.J.","year":"1983","unstructured":"Graham DY, Smith JL, Patterson DJ. Why do apparently healthy people use antacid tablets? AmJ Gastroenterol 1983; 78: 257-60.","journal-title":"AmJ Gastroenterol"},{"key":"ref_3","first-page":"727","article-title":"Recent views on the pathogenesis of gastrooesophageal reflux disease","volume-title":"Clinical Gastroenterology","volume":"1","author":"Dent, J.","year":"1987","unstructured":"Dent J. Recent views on the pathogenesis of gastrooesophageal reflux disease. In: Tytgat GNJ, ed. Baillere's Clinical Gastroenterology. London: Bailliere Tindall, 1987: 1: 727-45."},{"key":"ref_4","article-title":"Mechanisms of sphincter incompetence in patients with symptomatic","volume-title":"gastro-oesophageal reflux. Gastroenterology 1983; 84: 1135","author":"Dent, J.; Dodds, W.J.; Toouli, J.; Barnes, B.; Lewis, I.","unstructured":"Dent J, Dodds WJ, Toouli J, Barnes B, Lewis I. Mechanisms of sphincter incompetence in patients with symptomatic gastro-oesophageal reflux. Gastroenterology 1983; 84: 1135."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0140-6736(87)91332-8","article-title":"Effects of sleeping with the bed-head raised and of ranitidine in patients with severe peptic oesophagitis","volume":"ii:","author":"Harvey, R.F.; Gordon, P.C.; Hadley, N.","year":"1987","unstructured":"Harvey RF, Gordon PC, Hadley N, et al. Effects of sleeping with the bed-head raised and of ranitidine in patients with severe peptic oesophagitis. Lancet 1987; ii: 1200-3.","journal-title":"Lancet"},{"key":"ref_6","first-page":"119","article-title":"The esophagus. Handbook and atlas of endoscopy","author":"Savary, M.","year":"1978","unstructured":"Savary M, Miller G. In: Savary M, Miller G, eds. The esophagus. Handbook and atlas of endoscopy. Solothurn, Switzerland: Verlag Gassman AG, 1978: 119-205."},{"key":"ref_7","first-page":"441","volume-title":"Cimetidine in the treatment of symptomatic gastroesophageal reflux. Gastroenterology 1978; 74","author":"Behar, J.; Brand, D.L.; Brown, F.C.","unstructured":"Behar J, Brand DL, Brown FC, et al. Cimetidine in the treatment of symptomatic gastroesophageal reflux. Gastroenterology 1978; 74: 441-8."},{"key":"ref_8","first-page":"555","article-title":"A randomized, controlled evaluation of cimetidine","volume":"2","author":"Breen, K.J.; Desmond, P.V.; Whelan, G.","year":"1983","unstructured":"Breen KJ, Desmond PV, Whelan G. A randomized, controlled evaluation of cimetidine. MedjAust 1983; 2: 555-6.","journal-title":"MedjAust"},{"key":"ref_9","first-page":"149","article-title":"Cimetidine, metoclopramide, or placebo in the treatment of symptomatic gastroesophageal reflux. J7 Clin Gastroenterol","volume":"2","author":"Bright-Asare, P.; El-Bassoussi, M.","year":"1980","unstructured":"Bright-Asare P, El-Bassoussi M. Cimetidine, metoclopramide, or placebo in the treatment of symptomatic gastroesophageal reflux.J7 Clin Gastroenterol 1980; 2: 149-56."},{"key":"ref_10","first-page":"96","article-title":"Cimetidine in the treatment of reflux oesophagitis","volume":"2","author":"Brown, P.","year":"1979","unstructured":"Brown P. Cimetidine in the treatment of reflux oesophagitis. MedJAust 1979; 2: 96-7.","journal-title":"MedJAust"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/bmj.2.6188.472","article-title":"Cimetidine in the treatment of reflux oesophagitis with peptic stricture","volume":"2","author":"Ferguson, R.; Dronfield, M.W.; Atkinson, M.","year":"1979","unstructured":"Ferguson R, Dronfield MW, Atkinson M. Cimetidine in the treatment of reflux oesophagitis with peptic stricture. BMJ 1979; 2:472-4.","journal-title":"BMJ"},{"key":"ref_12","first-page":"237","article-title":"Cimetidine in the treatment of severe ulcerative reflux oesophagitis; results of an 8-week double-blind study and of subsequent long-term maintenance treatment","volume":"23","author":"Festen, H.P.M.; Driessen, W.M.M.; Lamers, C.B.H.; Van Tongeren, J.H.M.","year":"1980","unstructured":"Festen HPM, Driessen WMM, Lamers CBH, Van Tongeren JHM. Cimetidine in the treatment of severe ulcerative reflux oesophagitis; results of an 8-week double-blind study and of subsequent long-term maintenance treatment. Neth J Med 1980; 23: 237-40.","journal-title":"Neth J Med"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/BF01345293","article-title":"Controlled trial of cimetidine in reflux esophagitis","volume":"25","author":"Fiasse, R.; Hanin, C.; Lepot, A.; Descamps, C.; Lamy, F.; Dive, C.","year":"1980","unstructured":"Fiasse R, Hanin C, Lepot A, Descamps C, Lamy F, Dive C. Controlled trial of cimetidine in reflux esophagitis. Dig Dis Sci 1980; 25: 750-5.","journal-title":"Dig Dis Sci"},{"key":"ref_14","first-page":"21","article-title":"Cimetidine for the treatment of symptomatic gastro-oesophageal reflux","volume":"35","author":"Greaney, M.G.; Irvin, T.T.","year":"1981","unstructured":"Greaney MG, Irvin TT. Cimetidine for the treatment of symptomatic gastro-oesophageal reflux. Br J Clin Pract 1981; 35: 21-4.","journal-title":"Br J Clin Pract"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(78)91802-0","article-title":"Effect of cimetidine in symptomatic gastro-oesophageal reflux","volume":"ii:","author":"Powell-Jackson, P.; Barkley, H.; Northfield, T.C.","year":"1978","unstructured":"Powell-Jackson P, Barkley H, Northfield TC. Effect of cimetidine in symptomatic gastro-oesophageal reflux. Lancet 1978; ii: 1068-9.","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0016-5085(78)90133-6","article-title":"Oral cimetidine in reflux esophagitis: a double blind controlled trial","volume":"74","author":"Wesdorp, E.; Bartelsman, J.; Pape, K.; Dekker, W.; Tytgat, G.N.","year":"1978","unstructured":"Wesdorp E, Bartelsman J, Pape K, Dekker W, Tytgat GN. Oral cimetidine in reflux esophagitis: a double blind controlled trial. Gastroenterology 1978; 74: 821-4.","journal-title":"Gastroenterology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0016-5085(79)90223-3","article-title":"Cimetidine versus antacid in scleroderma with reflux esophagitis","volume":"77","author":"Petrokubi, R.J.; Jeffries, G.H.","year":"1979","unstructured":"Petrokubi RJ, Jeffries GH. Cimetidine versus antacid in scleroderma with reflux esophagitis. Gastroenterology 1979; 77: 691-5.","journal-title":"Gastroenterology"},{"key":"ref_18","first-page":"139","article-title":"Acute and maintenance treatments with cimetidine","volume":"21","author":"Kaul, B.; Petersen, H.; Erichsen, H.","year":"1986","unstructured":"Kaul B, Petersen H, Erichsen H, et al. Acute and maintenance treatments with cimetidine. ScandJ3 Gastroenterol 1986; 21: 139-45."},{"key":"ref_19","first-page":"616","article-title":"Cimetidine therapy for gastroesophageal reflux disease","volume":"143","author":"Archambault, A.P.; Farley, A.; Cleator, I.G.","year":"1985","unstructured":"Archambault AP, Farley A, Cleator IG, et al. Cimetidine therapy for gastroesophageal reflux disease. West J Med 1985; 143: 616-21.","journal-title":"West J Med"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/archinte.1982.00340210073016","article-title":"Bethanecol or cimetidine in the treatment of symptomatic reflux esophagitis","volume":"142","author":"Thanik, K.; Chey, W.Y.; Shak, A.; Hamilton, D.; Nadelson, N.","year":"1982","unstructured":"Thanik K, Chey WY, Shak A, Hamilton D, Nadelson N. Bethanecol or cimetidine in the treatment of symptomatic reflux esophagitis. Arch Intern Med 1982; 142: 1479-81.","journal-title":"Arch Intern Med"},{"key":"ref_21","first-page":"390","article-title":"v","volume":"9","author":"Hameeteman, W.","year":"1987","unstructured":"Hameeteman W, v d Boomgaard DM, Dekker W, Schrijver M, Wesdorp ICE, Tytgat GNJ. Sucralfate versus cimetidine in reflux esophagitis.. Clin Gastroenterol 1987; 9: 390-4.","journal-title":"Clin Gastroenterol; Sucralfate versus cimetidine in reflux esophagitis"},{"key":"ref_22","first-page":"297","article-title":"Overview of ranitidine in reflux oesophagitis: its effect on symptoms, endoscopic appearance and histology","volume-title":"The clinical use of ranitidine","author":"Berstad, A.","year":"1982","unstructured":"Berstad A. Overview of ranitidine in reflux oesophagitis: its effect on symptoms, endoscopic appearance and histology. In: Misiewicz JJ, Wormsley KG, eds. The clinical use of ranitidine. Oxford: Medicine Publishing Foundation, 1982: 297-304."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"558","DOI":"10.5694\/j.1326-5377.1983.tb122676.x","article-title":"Ranitidine and placebo in the treatment of reflux oesophagitis","volume":"2","author":"Goy, J.A.; Maynard, J.H.; McNauton, W.M.; O'Shea, A.","year":"1983","unstructured":"Goy JA, Maynard JH, McNauton WM, O'Shea A. Ranitidine and placebo in the treatment of reflux oesophagitis. Med J Aust 1983; 2: 558-61.","journal-title":"Med J Aust"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/00365528509089680","article-title":"Ranitidine and high dose antacid in reflux oesophagitis. A randomized placebo-controlled trial","volume":"20","author":"Grove 0, Bekker C, Jeppe-Hansen MG","year":"1985","unstructured":"Grove 0, Bekker C, Jeppe-Hansen MG, et al. Ranitidine and high dose antacid in reflux oesophagitis. A randomized placebo-controlled trial. Scand Jf Gastroenterol 1985; 20: 457-61.","journal-title":"Scand Jf Gastroenterol"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000199020","article-title":"Ranitidine in reflux oesophagitis","volume":"29","author":"Hine, K.R.; Holmes, G.K.T.; Melikian, V.; Lucey, M.; Fairclough, P.D.","year":"1984","unstructured":"Hine KR, Holmes GKT, Melikian V, Lucey M, Fairclough PD. Ranitidine in reflux oesophagitis. Digestion 1984; 29: 119-23.","journal-title":"Digestion"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3109\/00365528609011116","article-title":"Doubleblind crossover study of ranitidine and placebo in gastrooesophageal reflux disease","volume":"21","author":"Johansson, K.E.; Boeryd, B.; Johansson, K.; Tibbling, L.","year":"1986","unstructured":"Johansson KE, Boeryd B, Johansson K, Tibbling L. Doubleblind crossover study of ranitidine and placebo in gastrooesophageal reflux disease. Scand J Gastroenterol 1986; 21: 769-78.","journal-title":"Scand J Gastroenterol"},{"key":"ref_27","first-page":"175","article-title":"mg three times a day, in the treatment of reflux oesophagitis. A placebo-controlled, double-blind study. ScandJ'","volume":"150","author":"Lehtola, J.; Niemela, S.; Martikainen, J.; Krekela, I.","year":"1986","unstructured":"Lehtola J, Niemela S, Martikainen J, Krekela I. Ranitidine, 150 mg three times a day, in the treatment of reflux oesophagitis. A placebo-controlled, double-blind study. ScandJ' Gastroenterol 1986; 21: 175-80.","journal-title":"Ranitidine"},{"key":"ref_28","first-page":"9","article-title":"Ranitidine in the treatment of symptomatic gastroesophageal reflux disease","volume":"6","author":"Sherbaniuk, R.; Wensel, R.; Bailey, R.","year":"1984","unstructured":"Sherbaniuk R, Wensel R, Bailey R, et al. Ranitidine in the treatment of symptomatic gastroesophageal reflux disease. J Clin Gastroenterol 1984; 6: 9-15.","journal-title":"J Clin Gastroenterol"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/archinte.1987.00370080123022","article-title":"Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial","volume":"147","author":"Sontag, S.; Robinson, M.; McCallum, R.W.; Barwick, K.W.; Nardi, R.","year":"1987","unstructured":"Sontag S, Robinson M, McCallum RW, Barwick KW, Nardi R. Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial. Arch Intern Med 1987; 147: 1485-91.","journal-title":"Arch Intern Med"},{"key":"ref_30","first-page":"921","article-title":"Treatment of reflux oesophagitis with ranitidine","volume-title":"Gut","volume":"24","author":"Wesdorp, I.C.E.; Dekker, W.; Klinkenberg-Knol, E.C.","year":"1983","unstructured":"Wesdorp ICE, Dekker W, Klinkenberg-Knol EC. Treatment of reflux oesophagitis with ranitidine. Gut 1983; 24: 921-4."},{"key":"ref_31","first-page":"155","article-title":"Short-term treatment of reflux oesophagitis with ranitidine 300 mg nocte, Italian multicentre study","volume":"34","author":"Bovero, E.; Cheli, R.; Barbara, L.","year":"1987","unstructured":"Bovero E, Cheli R, Barbara L, et al. Short-term treatment of reflux oesophagitis with ranitidine 300 mg nocte, Italian multicentre study. Hepatogastroenterology 1987; 34:155-9.","journal-title":"Hepatogastroenterology"},{"key":"ref_32","first-page":"171","article-title":"Acute treatment of reflux oesophagitis: a multicentre study to compare 150 mg ranitidine twice daily with 300 mg ranitidine at bedtime","volume-title":"Aliment Pharmacol Therap","volume":"3","author":"Halvorsen, L.; Lee, F.I.; Wesdorp, I.C.E.; Johnson, N.J.; Mills, J.G.; Wood, JR","year":"1989","unstructured":"Halvorsen L, Lee FI, Wesdorp ICE, Johnson NJ, Mills JG, Wood JR. Acute treatment of reflux oesophagitis: a multicentre study to compare 150 mg ranitidine twice daily with 300 mg ranitidine at bedtime. Aliment Pharmacol Therap 1989; 3: 171-81."},{"key":"ref_33","first-page":"208","article-title":"Investigation of ranitidine 150 mg bd or 300 mg bd in the treatment of reflux disease","volume":"33","author":"Schaub, N.; Meyrick Thomas, J.; Misiewicz, J.J.; Lovell, D.; Trotman, I.F.","year":"1986","unstructured":"Schaub N, Meyrick Thomas J, Misiewicz JJ, Lovell D, Trotman IF. Investigation of ranitidine 150 mg bd or 300 mg bd in the treatment of reflux disease. Hepatogastroenterology 1986; 33: 208-13.","journal-title":"Hepatogastroenterology"},{"key":"ref_34","article-title":"Acute treatment of reflux oesophagitis: a multi-centre trial comparing ranitidine 150 mg bid with ranitidine","volume-title":"300 mg qid. Gastroenterology 1989; %: A242","author":"Johnson, N.J.; Mills, J.G.; Wood, JR","unstructured":"Johnson NJ, Mills JG, Wood JR. Acute treatment of reflux oesophagitis: a multi-centre trial comparing ranitidine 150 mg bid with ranitidine 300 mg qid. Gastroenterology 1989; %: A242."},{"key":"ref_35","first-page":"96","article-title":"Ranitidine vs metoclopramide in the medical treatment of reflux esophagitis","volume":"30","author":"Guslandi, M.; Testoni, P.A.; Passaretti, S.","year":"1983","unstructured":"Guslandi M, Testoni PA, Passaretti S, et al. Ranitidine vs metoclopramide in the medical treatment of reflux esophagitis. Hepatogastroenterology 1983; 30: 96-8.","journal-title":"Hepatogastroenterology"},{"key":"ref_36","first-page":"125","article-title":"Cisapride versus ranitidine in the treatment of reflux esophagitis","volume":"35","author":"Janisch, H.D.; Huttemann, W.; Bouzo, M.H.","year":"1988","unstructured":"Janisch HD, Huttemann W, Bouzo MH. Cisapride versus ranitidine in the treatment of reflux esophagitis. Hepatogastroenterology 1988; 35: 125-7.","journal-title":"Hepatogastroenterology"},{"key":"ref_37","first-page":"356","article-title":"Comparison between ranitidine and cimetidine in the treatment of reflux oesophagitis","volume":"77","author":"Fielding, J.F.; Doyle, G.D.","year":"1984","unstructured":"Fielding JF, Doyle GD. Comparison between ranitidine and cimetidine in the treatment of reflux oesophagitis. Ir MedJ 1984; 77: 356-7."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/00365528709090141","article-title":"Once daily famotidine for reflux esophagitis","volume":"134","author":"Sekiguchi, T.; Nishioka, T.; Kogure, M.","year":"1987","unstructured":"Sekiguchi T, Nishioka T, Kogure M, et al. Once daily famotidine for reflux esophagitis. Scand J Gastroenterol 1987; 22 (suppl 134): 51-4.","journal-title":"Scand J Gastroenterol"},{"key":"ref_39","first-page":"372","article-title":"BID regimens of an H2 receptor antagonist heal erosive esophagitis: results of a US double-blind, randomised multicenter trial","volume":"98","author":"Berenson, M.; Simon, T.J.; Berlin, R.G.","year":"1990","unstructured":"Berenson M, Simon TJ, Berlin RG, et al. BID regimens of an H2 receptor antagonist heal erosive esophagitis: results of a US double-blind, randomised multicenter trial. Gastroenterology 1990; 98: A372.","journal-title":"Gastroenterology"},{"key":"ref_40","first-page":"22935","article-title":"Dose-response effect of famotidine on patterns of gastrooesophageal reflux","volume":"2","author":"Orr, W.C.; Robinson, M.G.; Humphries, T.J.; Antonello, J.; Cagliola, A.","year":"1988","unstructured":"Orr WC, Robinson MG, Humphries TJ, Antonello J, Cagliola A. Dose-response effect of famotidine on patterns of gastrooesophageal reflux. Aliment Pharmacol Therap 1988; 2: 22935.","journal-title":"Aliment Pharmacol Therap"},{"key":"ref_41","first-page":"91","article-title":"Nizatidine 150 mg bid relieves symptoms and decreases severity of esophagitis in gastro-oesophageal reflux disease","volume":"96","author":"Cloud, M.; Offen, W.","year":"1989","unstructured":"Cloud M, Offen W. Nizatidine 150 mg bid relieves symptoms and decreases severity of esophagitis in gastro-oesophageal reflux disease. Gastroenterology 1989; 96: A91.","journal-title":"Gastroenterology"},{"key":"ref_42","first-page":"201","article-title":"A comparison of two doses of nizatidine versus placebo in the treatment of reflux oesophagitis","volume":"4","author":"Quik, R.P.F.; Cooper, M.J.; Gleeson, M.","year":"1990","unstructured":"Quik RPF, Cooper MJ, Gleeson M, et al. A comparison of two doses of nizatidine versus placebo in the treatment of reflux oesophagitis. Aliment Pharmacol Therap 1990; 4: 201-11.","journal-title":"Aliment Pharmacol Therap"},{"key":"ref_43","first-page":"156","article-title":"A comparison of two doses of nizatidine in reflux oesophagitis","volume":"27","author":"Berges, W.; Lux, G.; Simon, B.; Weinbeck, M.; Quik, R.","year":"1989","unstructured":"Berges W, Lux G, Simon B, Weinbeck M, Quik R. A comparison of two doses of nizatidine in reflux oesophagitis. Z Gastroenterol 1989; 27: 156.","journal-title":"Z Gastroenterol"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-104-1-21","article-title":"Treatment of severe reflux esophagitis with cimetidine and metoclopramide","volume":"104","author":"Lieberman, D.A.; Keefe, E.B.","year":"1986","unstructured":"Lieberman DA, Keefe EB. Treatment of severe reflux esophagitis with cimetidine and metoclopramide. Ann Intern Med 1986; 104:21-6.","journal-title":"Ann Intern Med"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1136\/bmj.286.6381.1863","article-title":"Cimetidine and metoclopramide in oesophageal reflux disease","volume":"286","author":"Temple, J.G.; Bradby, G.V.H.; O'Connor, F.","year":"1983","unstructured":"Temple JG, Bradby GVH, O'Connor F, et al. Cimetidine and metoclopramide in oesophageal reflux disease. BMJ 1983; 286: 1863-4.","journal-title":"BMJ"},{"key":"ref_46","first-page":"144","article-title":"Does cisapride added to H2-receptor-blocking treatment improve healing rates in patients with esophagitis?","volume":"34","author":"Wienbeck, M.","year":"1986","unstructured":"Wienbeck M. Does cisapride added to H2-receptor-blocking treatment improve healing rates in patients with esophagitis? Digestion 1986; 34: 144.","journal-title":"Digestion"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1136\/gut.29.5.675","article-title":"Combination therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial","volume":"29","author":"Galmiche, J.P.; Brandstatter, G.; Evreux, M.","year":"1988","unstructured":"Galmiche JP, Brandstatter G, Evreux M, et al. Combination therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial. Gut 1988; 29: 675-81.","journal-title":"Gut"},{"issue":"6","key":"ref_48","first-page":"77","article-title":"Combination therapy of sucralfate and cimetidine, compared with sucralfate monotherapy, in patients with peptic reflux esophagitis","volume":"86","author":"Schotborgh, R.H.; Hameeteman, W.; Dekker, W.","year":"1989","unstructured":"Schotborgh RH, Hameeteman W, Dekker W, et al. Combination therapy of sucralfate and cimetidine, compared with sucralfate monotherapy, in patients with peptic reflux esophagitis. AmJyMed 1989; 86 (suppl 6A): 77-80.","journal-title":"AmJyMed"},{"key":"ref_49","article-title":"Omeprazole heals esophagitis by elevation","volume-title":"of intragastric pH. Gastroenterology 1985; 88: 1363","author":"Dent, J.; Downton, J.; Buckle, P.","unstructured":"Dent J, Downton J, Buckle P, et al. Omeprazole heals esophagitis by elevation of intragastric pH. Gastroenterology 1985; 88: 1363."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0016-5085(88)90162-X","article-title":"Healing and relapse of severe peptic esophagitis after treatment with omeprazole","volume":"95","author":"Hetzel, D.J.; Dent, J.; Reed, W.D.","year":"1988","unstructured":"Hetzel DJ, Dent J, Reed WD, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95: 903-12.","journal-title":"Gastroenterology"},{"key":"ref_51","article-title":"Omeprazole is superior to ranitidine","volume-title":"the treatment of reflux esophagitis. Gastroenterology 1986; 90: 1385","author":"Dammann, H.G.; Blum, A.L.; Lux, G.","unstructured":"Dammann HG, Blum AL, Lux G, et al. Omeprazole is superior to ranitidine in the treatment of reflux esophagitis. Gastroenterology 1986; 90: 1385."},{"key":"ref_52","first-page":"621","article-title":"Omeprazole versus ranitidine in erosive oesophagitis","volume":"ii:","author":"Zeitoun, P.; Desiars de Keranroue, N.; Isal, J.P.","year":"1987","unstructured":"Zeitoun P, Desiars de Keranroue N, Isal JP. Omeprazole versus ranitidine in erosive oesophagitis. Lancet 1987; ii: 621-22.","journal-title":"Lancet"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/00365528809093923","article-title":"Omeprazole or ranitidine in the treatment of reflux esophagitis","volume":"23","year":"1988","unstructured":"Sandmark S, Carlsson R, Fausa 0, Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Scand J Gastroenterol 1988; 23: 625-32.","journal-title":"Scand J Gastroenterol"},{"key":"ref_54","first-page":"1141","article-title":"The effect of omeprazole or ranitidine treatment on 24-hour oesophageal acidity in patients with reflux esophagitis","volume":"23","author":"Ruth, M.; Enbom, H.; Lundell, H.; Lonroth, H.; Sandberg, N.; Sandmark, S.","year":"1988","unstructured":"Ruth M, Enbom H, Lundell H, Lonroth H, Sandberg N, Sandmark S. The effect of omeprazole or ranitidine treatment on 24-hour oesophageal acidity in patients with reflux esophagitis. ScandJ7 Gastroenterol 1988; 23: 1141-6."},{"key":"ref_55","first-page":"8992","article-title":"Omeprazole and ranitidine in treatment of reflux oesophagitis: a double blind comparative trial","volume":"296","author":"Havelund, T.; Laursen, L.S.; Skoubo-Kristensen, E.","year":"1988","unstructured":"Havelund T, Laursen LS, Skoubo-Kristensen E, et al. Omeprazole and ranitidine in treatment of reflux oesophagitis: a double blind comparative trial. BMJ 1988; 296: 8992.","journal-title":"BMJ"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/BF01798351","article-title":"Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis","volume":"33","author":"Vantrappen, G.; Rutgeerts, L.; Schurmans, P.; Coenegrachts, J.-L.","year":"1988","unstructured":"Vantrappen G, Rutgeerts L, Schurmans P, Coenegrachts J-L. Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis. Dig Dis Sci 1988; 33: 523-9.","journal-title":"Dig Dis Sci"},{"key":"ref_57","first-page":"349","article-title":"Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis","volume":"i:","author":"Klinkenberg-Knol, E.C.; Jansen, J.M.B.J.; Festen, H.P.M.; Meuwissen, S.G.M.; Lamers, C.B.H.W.","year":"1987","unstructured":"Klinkenberg-Knol EC, Jansen JMBJ, Festen HPM, Meuwissen SGM, Lamers CBHW. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet 1987; i: 349-51.","journal-title":"Lancet"},{"key":"ref_58","first-page":"1567","article-title":"Comparison of the effects of two doses of omeprazole on 24-hour oesophageal pH in gastroesophageal reflux disease","volume":"92","author":"Pasqual, J.C.; Hemery, P.; Bruley, S.; Galmiche, J.P.","year":"1987","unstructured":"Pasqual JC, Hemery P, Bruley S, Galmiche JP. Comparison of the effects of two doses of omeprazole on 24-hour oesophageal pH in gastroesophageal reflux disease. Gastroenterology 1987; 92: 1567.","journal-title":"Gastroenterology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/gut.31.5.509","article-title":"Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring","volume":"31","author":"Dehn, T.C.B.; Shepherd, H.A.; Colin-Jones, Kettlewell; MGW, Carroll; N.J.H.","year":"1990","unstructured":"Dehn TCB, Shepherd HA, Colin-Jones, Kettlewell MGW, Carroll NJH. Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring. Gut 1990; 31: 509-13.","journal-title":"Gut"},{"key":"ref_60","first-page":"221","article-title":"The effects of omeprazole and ranitidine on 24-hour pH in the distal oesophagus of patients with reflux oesophagitis","volume":"2","author":"Klinkenberg-Knol, E.C.; Festen, H.P.M.; Meuwissen, S.G.M.","year":"1988","unstructured":"Klinkenberg-Knol EC, Festen HPM, Meuwissen SGM. The effects of omeprazole and ranitidine on 24-hour pH in the distal oesophagus of patients with reflux oesophagitis. AlimentPharmnacol Therap 1988; 2: 221-7.","journal-title":"AlimentPharmnacol Therap"},{"key":"ref_61","first-page":"1025","article-title":"Effects of long term maintenance therapy on gastroesophageal reflux disease","volume":"82","author":"Bright-Asare, P.; Behar, J.; Brand, D.L.","year":"1982","unstructured":"Bright-Asare P, Behar J, Brand DL, et al. Effects of long term maintenance therapy on gastroesophageal reflux disease. Gastroenterology 1982; 82: 1025.","journal-title":"Gastroenterology"},{"key":"ref_62","first-page":"602","article-title":"Refractory erosive oesophagitis: results of maintenance treatment with high dose H2 receptor antagonists or omeprazole","volume":"31","author":"Bardhan, K.D.; Daly, M.J.; Singh, S.; Morris, P.; Thompson, M.; Hinchliffe, R.F.C.","year":"1990","unstructured":"Bardhan KD, Daly MJ, Singh S, Morris P, Thompson M, Hinchliffe RFC. Refractory erosive oesophagitis: results of maintenance treatment with high dose H2 receptor antagonists or omeprazole. Gut 1990; 31: A602.","journal-title":"Gut"},{"key":"ref_63","first-page":"367","article-title":"Comparison of two dosage regimens of omeprazole - 10 mg once daily and 20 mg weekends - as prophylaxis against recurrence of reflux esophagitis","volume":"98","author":"Isal, J.P.; Zeitoun, P.; Barbier, P.; Cayphas, J.P.; Carlsson, R.","year":"1990","unstructured":"Isal JP, Zeitoun P, Barbier P, Cayphas JP, Carlsson R. Comparison of two dosage regimens of omeprazole - 10 mg once daily and 20 mg weekends - as prophylaxis against recurrence of reflux esophagitis. Gastroenterology 1990; 98: A367.","journal-title":"Gastroenterology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3109\/00365528609015167","article-title":"Gastric secretion and reflux pattern in reflux oesophagitis before and during ranitidine treatment","volume":"21","author":"Johansson, K.E.; Tibbling, L.","year":"1986","unstructured":"Johansson KE, Tibbling L. Gastric secretion and reflux pattern in reflux oesophagitis before and during ranitidine treatment. ScandJ Gastroenterol 1986; 21: 487-92.","journal-title":"ScandJ Gastroenterol"},{"key":"ref_65","first-page":"32","article-title":"Basal acid output and gastric acid hypersecretion in patients with gastroesophageal reflux disease","volume":"98","author":"Collen, M.J.; Gallagher, J.E.","year":"1990","unstructured":"Collen MJ, Gallagher JE. Basal acid output and gastric acid hypersecretion in patients with gastroesophageal reflux disease. Gastroenterology 1990; 98: A32.","journal-title":"Gastroenterology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/gut.28.8.946","article-title":"H2 antagonists in the treatment of reflux oesophagitis: can physiological studies predict the response?","volume":"28","author":"Robertson, D.A.F.; Aldersley, M.A.; Shepherd, H.; Lloyd, R.S.; Smith, C.L.","year":"1987","unstructured":"Robertson DAF, Aldersley MA, Shepherd H, Lloyd RS, Smith CL. H2 antagonists in the treatment of reflux oesophagitis: can physiological studies predict the response? Gut 1987; 28: 946-9.","journal-title":"Gut"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/0016-5085(90)90285-9","article-title":"Gastric hypersecretion in refractory gastroesophageal reflux disease","volume":"98","author":"Collen, M.J.; Lewis, J.H.; Benjamin, S.B.","year":"1990","unstructured":"Collen MJ, Lewis JH, Benjamin SB. Gastric hypersecretion in refractory gastroesophageal reflux disease. Gastroenterology 1990; 98: 654-61.","journal-title":"Gastroenterology"},{"key":"ref_68","first-page":"36","article-title":"Acid reflux and oesophagitis - day or night?","volume":"1","author":"Jenkinson, L.R.; Norris, T.L.; Barlow, A.P.; Watson, A.","year":"1990","unstructured":"Jenkinson LR, Norris TL, Barlow AP, Watson A. Acid reflux and oesophagitis - day or night? Gullet 1990; 1: 36-44.","journal-title":"Gullet"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1136\/gut.28.9.1120","article-title":"Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs","volume":"28","author":"Jones, D.B.; Howden, C.W.; Burget, D.W.; Kerr, G.D.; Hunt, R.H.","year":"1987","unstructured":"Jones DB, Howden CW, Burget DW, Kerr GD, Hunt RH. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut 1987; 28: 1120-7.","journal-title":"Gut"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2036.1990.tb00445.x","article-title":"The relationship between suppression of acidity and gastric ulcer healing","volume":"4","author":"Howden, C.W.; Hunt, R.H.","year":"1990","unstructured":"Howden CW, Hunt RH. The relationship between suppression of acidity and gastric ulcer healing. Aliment Pharmacol Therap 1990; 4: 25-34.","journal-title":"Aliment Pharmacol Therap"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0016-5085(90)91015-X","article-title":"Is there an optimal degree of acid suppression in healing duodenal ulcer? A model of the relationship between ulcer healing and acid suppression","volume":"99","author":"Burget, D.W.; Chiverton, S.G.; Hunt, R.H.","year":"1990","unstructured":"Burget DW, Chiverton SG, Hunt RH. Is there an optimal degree of acid suppression in healing duodenal ulcer? A model of the relationship between ulcer healing and acid suppression. Gastroenterology 1990; 99: 345-51.","journal-title":"Gastroenterology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1001\/archinte.1987.00370100031006","article-title":"Medical therapy for chronic reflux esophagitis","volume":"147","author":"Lieberman, D.A.","year":"1987","unstructured":"Lieberman DA. Medical therapy for chronic reflux esophagitis. Arch Intern Med 1987; 147: 1717-20.","journal-title":"Arch Intern Med"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM197508072930602","article-title":"Medical and surgical management of reflux esophagitis","volume":"293","author":"Behar, J.; Sheahan, D.G.; Biancani, P.; Spiro, H.M.; Storer, E.H.","year":"1975","unstructured":"Behar J, Sheahan DG, Biancani P, Spiro HM, Storer EH. Medical and surgical management of reflux esophagitis. N EnglJ Med 1975; 293: 263-8.","journal-title":"N EnglJ Med"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3109\/00365528609011117","article-title":"Maintenance treatment with ranitidine compared with fundoplication in gastrooesophageal reflux disease","volume":"21","author":"Johansson, K.E.; Tibbling, L.","year":"1986","unstructured":"Johansson KE, Tibbling L. Maintenance treatment with ranitidine compared with fundoplication in gastrooesophageal reflux disease. Scand J Gastroenterol 1986; 21: 779-88.","journal-title":"Scand J Gastroenterol"},{"key":"ref_75","first-page":"370","article-title":"A prospective, randomized trial of medical and surgical therapies for gastroesophageal reflux disease (GERD)","volume":"98","author":"Spechler, S.J.; Williford, W.O.","year":"1990","unstructured":"Spechler SJ, Williford WO. A prospective, randomized trial of medical and surgical therapies for gastroesophageal reflux disease (GERD). Gastroenterology 1990; 98: A370.","journal-title":"Gastroenterology"},{"issue":"166","key":"ref_76","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/00365528909091255","article-title":"The clinical safety of omeprazole","volume":"24","author":"Solvell, L.","year":"1989","unstructured":"Solvell L. The clinical safety of omeprazole. Scand J Gastroenterol 1989; 24 (suppl 166): 106-10.","journal-title":"Scand J Gastroenterol"},{"issue":"166","key":"ref_77","first-page":"19","article-title":"A review of long-term acid inhibition in animals. ScandJ7 Gastroenteol","volume":"24","author":"Carlsson, E.","year":"1989","unstructured":"Carlsson E. A review of long-term acid inhibition in animals. ScandJ7 Gastroenteol 1989; 24 (suppl 166): 19-23."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000200245","article-title":"Enterochromaffin-like cell carcinoids in the rat gastric mucosa following long-term administration of ranitidine","volume":"45","author":"Havu, N.; Mattsson, H.; Ekman, L.; Carlsson, E.","year":"1990","unstructured":"Havu N, Mattsson H, Ekman L, Carlsson E. Enterochromaffin-like cell carcinoids in the rat gastric mucosa following long-term administration of ranitidine. Digestion 1990; 45: 189-95.","journal-title":"Digestion"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000200230","article-title":"Effects of partial resection of acid-secreting mucosa on plasma gastrin and enterochromaffin-like cells in the rat stomach","volume":"45","author":"Ryberg, B.; Carlsson, E.; Carlsson, K.","year":"1990","unstructured":"Ryberg B, Carlsson E, Carlsson K, et al. Effects of partial resection of acid-secreting mucosa on plasma gastrin and enterochromaffin-like cells in the rat stomach. Digestion 1990; 45: 102-8.","journal-title":"Digestion"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0016-5085(88)80066-0","article-title":"Time-course of development and reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion","volume":"95","author":"Larsson, H.; Carlsson, E.; Hakanson, R.","year":"1988","unstructured":"Larsson H, Carlsson E, Hakanson R, et al. Time-course of development and reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion. Gastroenterology 1988; 95: 1477-86.","journal-title":"Gastroenterology"},{"key":"ref_81","first-page":"444","article-title":"Gastrin controls ECLcell and stem cell proliferation rate in the rat stomach. In: Abstracts of the World Congress of Gastroenterology","author":"Ryberg, B.; Tielmans, Y.; Axelson, J.","year":"1990","unstructured":"Ryberg B, Tielmans Y, Axelson J, et al. Gastrin controls ECLcell and stem cell proliferation rate in the rat stomach. In: Abstracts of the World Congress of Gastroenterology. Sydney 1990. Abingdon: The Medicine Group (UK) Ltd, 1990: 444."},{"key":"ref_82","first-page":"929","article-title":"Mortality from gastric cancer following gastric surgery for peptic ulcer","volume":"i:","author":"Caygill, C.P.J.; Hill, M.J.; Kirkham, J.S.; Northfield, T.C.","year":"1986","unstructured":"Caygill CPJ, Hill MJ, Kirkham JS, Northfield TC. Mortality from gastric cancer following gastric surgery for peptic ulcer. Lancet 1986; i: 929-31.","journal-title":"Lancet"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1136\/gut.29.11.1588","article-title":"Mortality caused by stomach cancer after remote partial gastrectomy for benign conditions: 40 years offollow up ofan Amsterdam cohort of 2633 postgastrectomy patients","volume":"29","author":"Offerhaus, G.J.A.; Tersmette, A.C.; Huibregtse, K.","year":"1988","unstructured":"Offerhaus GJA, Tersmette AC, Huibregtse K, et al. Mortality caused by stomach cancer after remote partial gastrectomy for benign conditions: 40 years offollow up ofan Amsterdam cohort of 2633 postgastrectomy patients. Gut 1988; 29: 1588-90.","journal-title":"Gut"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000225806","article-title":"Promoting effect of partial gastrectomy on carcinogenesis in the remnant stomach of rats after oral administration of N-Methyl-NNitro-N-Nitrosoguanidine","volume":"41","author":"Sano, C.; Kumashiro, R.; Saito, T.; Inokuchi, K.","year":"1984","unstructured":"Sano C, Kumashiro R, Saito T, Inokuchi K. Promoting effect of partial gastrectomy on carcinogenesis in the remnant stomach of rats after oral administration of N-Methyl-NNitro-N-Nitrosoguanidine. Oncology 1984; 41: 124-8.","journal-title":"Oncology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1136\/gut.31.11.1217","article-title":"Carcinoma of the gastric stump: risks and pathogenesis","volume":"31","author":"Northfield, T.C.; Hall, C.N.","year":"1990","unstructured":"Northfield TC, Hall CN. Carcinoma of the gastric stump: risks and pathogenesis. Gut 1990; 31: 1217-9.","journal-title":"Gut"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.33.1.118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T11:19:32Z","timestamp":1765624772000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.33.1.118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,1]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[1992,1,1]]},"published-print":{"date-parts":[[1992,1]]}},"alternative-id":["10.1136\/gut.33.1.118"],"URL":"https:\/\/doi.org\/10.1136\/gut.33.1.118","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,1]]}}}